BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19462222)

  • 1. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
    Baumanis L; Evans JP; Callanan N; Susswein LR
    J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
    Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
    Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
    Bradbury AR; Patrick-Miller L; Fetzer D; Egleston B; Cummings SA; Forman A; Bealin L; Peterson C; Corbman M; O'Connell J; Daly MB
    Clin Genet; 2011 Feb; 79(2):125-31. PubMed ID: 21039431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
    Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
    Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
    Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
    Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
    Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
    Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.
    Peshkin BN; Kelly S; Nusbaum RH; Similuk M; DeMarco TA; Hooker GW; Valdimarsdottir HB; Forman AD; Joines JR; Davis C; McCormick SR; McKinnon W; Graves KD; Isaacs C; Garber J; Wood M; Jandorf L; Schwartz MD
    J Genet Couns; 2016 Jun; 25(3):472-82. PubMed ID: 26455498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
    Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
    Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
    Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
    Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
    Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
    Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA1/BRCA2 genetic testing.
    Bracke X; Roberts J; McVeigh TP
    J Genet Couns; 2021 Apr; 30(2):563-573. PubMed ID: 33131182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.
    O'Shea R; Meany M; Carroll C; Cody N; Healy D; Green A; Lynch SA
    J Genet Couns; 2016 Jun; 25(3):422-31. PubMed ID: 26407988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
    Jenkins J; Calzone KA; Dimond E; Liewehr DJ; Steinberg SM; Jourkiv O; Klein P; Soballe PW; Prindiville SA; Kirsch IR
    Genet Med; 2007 Aug; 9(8):487-95. PubMed ID: 17700386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
    Gilmore MJ; Leo MC; Amendola LM; Goddard KAB; Ezzell Hunter J; Joseph G; Kauffman TL; Rolf B; Shuster E; Zepp JM; Wilfond BS; Biesecker BB
    Transl Behav Med; 2024 Jun; 14(7):377-385. PubMed ID: 38190737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.